Top compounds associated with response to XPC


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC 0.064 0.2
mRNA tivozanib CTRPv2 pan-cancer AAC 0.045 0.2
mRNA tivozanib GDSC1000 pan-cancer AAC -0.002 1
mRNA tosedostat CTRPv2 pan-cancer AAC 0.031 0.4
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.0081 0.8
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.034 0.4
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.026 0.4
mRNA trifluoperazine CTRPv2 pan-cancer AAC 0.028 0.5
mRNA triptolide CTRPv2 pan-cancer AAC 0.041 0.3
mRNA tubastatin A CTRPv2 pan-cancer AAC 0.039 0.4
Download CSV